Contribution of altered signal transduction associated to glutamate receptors in brain to the neurological alterations of hepatic encephalopathy

World Journal of Gastroenterology

Volumn 12, Issue 48, 2006, Pages 7737-7743

  Felipo, Vicente ^a  

^a CENTRO DE INVESTIGACIÓN PRÍNCIPE FELIPE   (Spain)

Author keywords

cGMP; Cognitive function; Glutamate receptors; Hepatic encephalopathy; Metabotropic glutamate receptors; Motor function; Neurological alterations; Nitric oxide; NMDA receptors

Indexed keywords

CALMODULIN; CYCLIC GMP; GLUTAMATE RECEPTOR; GLUTAMIC ACID; GUANYLATE CYCLASE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; NEURONAL NITRIC OXIDE SYNTHASE; NITRIC OXIDE;

BRADYKINESIA; BRAIN FUNCTION; COGNITION; COGNITIVE DEFECT; COMA; DEATH; DISEASE MODEL; EDITORIAL; GENE ACTIVATION; HEPATIC ENCEPHALOPATHY; HUMAN; HYPOKINESIA; IN VIVO STUDY; INTELLIGENCE; LEARNING DISORDER; LIVER DISEASE; MOTOR ACTIVITY; MOTOR DYSFUNCTION; NEUROLOGIC DISEASE; NEUROTRANSMISSION; NONHUMAN; PROGNOSIS; PROTEIN FUNCTION; PSYCHOMOTOR DISORDER; QUALITY OF LIFE; SIGNAL TRANSDUCTION; SUBSTANTIA NIGRA;

EID: 33846192274     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.v12.i48.7737     Document Type: Editorial

References (59)

1. Felipo V, Butterworth RF. Neurobiology of ammonia. Prog Neurobiol 2002; 67: 259-279
2. Shawcross DL, Davies NA, Williams R, Jalan R. Systemic inflammatory response exacerbates the neuropsychological effects of induced hyperammonemia in cirrhosis. J Hepatol 2004; 40: 247-254
3. Bustamante J, Rimola A, Ventura PJ, Navasa M, Cirera I, Reggiardo V, Rodes J. Prognostic significance of hepatic encephalopathy in patients with cirrhosis. J Hepatol 1999; 30: 890-895
4. Hui AY, Chan HL, Leung NW, Hung LC, Chan FK, Sung JJ. Survival and prognostic indicators in patients with hepatitis B virus-related cirrhosis after onset of hepatic decompensation. J Clin Gastroenterol 2002; 34: 569-572
5. Amodio P, Montagnese S, Gatta A, Morgan MY. Characteristics of minimal hepatic encephalopathy. Metab Brain Dis 2004; 19: 253-267
6. Ferenci P, Lockwood A, Mullen K, Tarter R, Weissenborn K, Blei AT. Hepatic encephalopathy - definition, nomenclature, diagnosis, and quantification: final report of the working party at the 11th World Congresses of Gastroenterology, Vienna, 1998. Hepatology 2002; 35: 716-721
7. Romero-Gómez M, Boza F, Garcia Valdecasas MS, García E, Aguilar Reina J. Subclinical hepatic encephalopathy predicts the development of overt hepatic encephalopathy. Am J Gastroenterol 2001; 96: 2718-2723
8. Das A, Dhiman RK, Saraswat VA, Verma M, Naik SR. Prevalence and natural history of subclinical hepatic encephalopathy in cirrhosis. J Gastroenterol Hepatol 2001; 16: 531-535
9. Groeneweg M, Quero JC, De Bruijn I, Hartmann IJ, Essink-bot ML, Hop WC, Schalm SW. Subclinical hepatic encephalopathy impairs daily functioning. Hepatology 1998; 28: 45-49
10. Wein C, Koch H, Popp B, Oehler G, Schauder P. Minimal hepatic encephalopathy impairs fitness to drive. Hepatology 2004; 39: 739-745
11. Iguchi H, Kato KI, Ibayashi H. Melatonin serum levels and metabolic clearance rate in patients with liver cirrhosis. J Clin Endocrinol Metab 1982; 54: 1025-1027
12. Steindl PE, Finn B, Bendok B, Rothke S, Zee PC, Blei AT. Disruption of the diurnal rhythm of plasma melatonin in cirrhosis. Ann Intern Med 1995; 123: 274-277
13. Garfinkel D, Zisapel N. Liver cirrhosis and circadian rhythm. Ann Intern Med 1996; 125: 154
14. Cordoba J, Cabrera J, Lataif L, Penev P, Zee P, Blei AT. High prevalence of sleep disturbance in cirrhosis. Hepatology 1998; 27: 339-345
15. Groeneweg M, Quero JC, De Bruijn I, Hartmann IJ, Essink-bot ML, Hop WC, Schalm SW. Subclinical hepatic encephalopathy impairs daily functioning. Hepatology 1998; 28: 45-49
16. Schomerus H, Hamster W, Blunck H, Reinhard U, Mayer K, Dolle W. Latent portasystemic encephalopathy. I. Nature of cerebral functional defects and their effect on fitness to drive. Dig Dis Sci 1981; 26: 622-630
17. Schomerus H, Hamster W. Quality of life in cirrhotics with minimal hepatic encephalopathy. Metab Brain Dis 2001; 16: 37-41
18. Srivastava A, Mehta R, Rothke SP, Rademaker AW, Blei AT. Fitness to drive in patients with cirrhosis and portal-systemic shunting: a pilot study evaluating driving performance. J Hepatol 1994; 21: 1023-1028
19. Amodio P, Del Piccolo F, Marchetti P, Angeli P, Iemmolo R, Caregaro L, Merkel C, Gerunda G, Gatta A. Clinical features and survivial of cirrhotic patients with subclinical cognitive alterations detected by the number connection test and computerized psychometric tests. Hepatology 1999; 29: 1662-1667
20. Hartmann IJ, Groeneweg M, Quero JC, Beijeman SJ, de Man RA, Hop WC, Schalm SW. The prognostic significance of subclinical hepatic encephalopathy. Am J Gastroenterol 2000; 95: 2029-2034
21. Tarter RE, Arria AM, Carra J, Van Thiel DH. Memory impairments concomitant with nonalcoholic cirrhosis. Int J Neurosci 1987; 32: 853-859
22. Weissenborn K, Heidenreich S, Giewekemeyer K, Ruckert N, Hecker H. Memory function in early hepatic encephalopathy. J Hepatol 2003; 39: 320-325
23. Gilberstadt SJ, Gilberstadt H, Zieve L, Buegel B, Collier RO Jr, McClain CJ. Psychomotor performance defects in cirrhotic patients without overt encephalopathy. Arch Intern Med 1980; 140: 519-521
24. Rehnstrom S, Simert G, Hansson JA, Johnson G, Vang J. Chronic hepatic encephalopathy. A psychometrical study. Scand J Gastroenterol 1977; 12: 305-311
25. Rikkers L, Jenko P, Rudman D, Freides D. Subclinical hepatic encephalopathy: detection, prevalence, and relationship to nitrogen metabolism. Gastroenterology 1978; 75: 462-469
26. Tarter RE, Hegedus AM, Van Thiel DH, Schade RR, Gavaler JS, Starzl TE. Nonalcoholic cirrhosis associated with neuropsychological dysfunction in the absence of overt evidence of hepatic encephalopathy. Gastroenterology 1984; 86: 1421-1427
27. McCrea M, Cordoba J, Vessey G, Blei AT, Randolph C. Neuropsychological characterization and detection of subclinical hepatic encephalopathy. Arch Neurol 1996; 53: 758-763
28. Weissenborn K, Heidenreich S, Ennen J, Ruckert N, Hecker H. Attention deficits in minimal hepatic encephalopathy. Metab Brain Dis 2001; 16: 13-19
29. Schomerus H, Hamster W. Neuropsychological aspects of portal-systemic encephalopathy. Metab Brain Dis 1998; 13: 361-377
30. Jover R, Company L, Gutierrez A, Lorente M, Zapater P, Poveda MJ, Such J, Pascual S, Palazon JM, Carnicer F, Ferrandis F, Perez-Mateo M. Clinical significance of extrapyramidal signs in patients with cirrhosis. J Hepatol 2005; 42: 659-665
31. Bengtsson F, Nobin A, Falck B, Gage FH, Jeppsson B. Portacaval shunt in the rat: selective alterations in behavior and brain serotonin. Pharmacol Biochem Behav 1986; 24: 1611-1616
32. Bergqvist PB, Werner ER, Apelqvist G, Bugge M, Wachter H, Bengtsson F. Brain biopterin metabolism in chronic experimental hepatic encephalopathy. Metab Brain Dis 1995; 10: 143-157
33. Martin JR. Discordant motor activity levels of portacaval-shunted rats in runway and swim tests. Behav Neurosci 1986; 100: 427-437
34. Steindl PE, Coy DL, Finn B, Zee PC, Blei AT. A low-protein diet ameliorates disrupted diurnal locomotor activity in rats after portacaval anastomosis. Am J Physiol 1996; 271: G555-G560
35. Theander B, Apelqvist G, Bugge M, Andersson G, Hindfelt B, Bengtsson F. Gender and diurnal effects on specific open-field behavioral patterns in the portacaval shunted rat. Metab Brain Dis 1996; 12: 47-59
36. Erceg S, Monfort P, Hernandez-Viadel M, Rodrigo R, Montoliu C, Felipo V. Oral administration of sildenafil restores learning ability in rats with hyperammonemia and with portacaval shunts. Hepatology 2005; 41: 299-306
37. Erceg S, Monfort P, Hernandez-Viadel M, Llansola M, Montoliu C, Felipo V. Restoration of learning ability in hyperammonemic rats by increasing extracellular cGMP in brain. Brain Res 2005; 1036: 115-121
38. Aguilar MA, Minarro J, Felipo V. Chronic moderate hyperammonemia impairs active and passive avoidance behavior and conditional discrimination learning in rats. Exp Neurol 2000; 161:704-713
39. Cauli O, Llansola M, Erceg S, Felipo V. Hypolocomotion in rats with chronic liver failure is due to increased glutamate and activation of metabotropic glutamate receptors in substantia nigra. J Hepatol 2006; 45: 654-661
40. Monfort P, Munoz MD, ElAyadi A, Kosenko E, Felipo V. Effects of hyperammonemia and liver failure on glutamatergic neurotransmission. Metab Brain Dis 2002; 17: 237-250
41. Felipo V, Minana MD, Grisolia S. Long-term ingestion of ammonium increases acetylglutamate and urea levels without affecting the amount of carbamoyl-phosphate synthase. Eur J Biochem 1988; 176: 567-571
42. Azorin I, Minana MD, Felipo V, Grisolia S. A simple animal model of hyperammonemia. Hepatology 1989; 10: 311-314
43. Hermenegildo C, Montoliu C, Llansola M, Muñoz; MD, Gaztelu JM, Miñana MD, Felipo V. Chronic hyperammonemia impairs the glutamate-nitric oxide-cyclic GMP pathway in cerebellar neurons in culture and in the rat in vivo. Eur J Neurosci 1998; 10: 3201-3209
44. Monfort P, Corbalán R, Martínez L, Lopez-Talavera J, Cordoba J, Felipo V. Altered content and modulation of soluble guanylate cyclase in the cerebellum of rats with portacaval anastomosis. Neuroscience 2001; 104: 1119-1125
45. Corbalán R, Chatauret N, Behrends S, Butterworth RF, Felipo V. Region selective alterations of soluble guanylate cyclase content and modulation in brain of cirrhotic patients. Hepatology 2002; 36: 1155-1162
46. Apelqvist G, Hindfelt B, Andersson G, Bengtsson F. Diurnal and gender effects by chronic portacaval shunting in rats on spontaneous locomotor and rearing activities in an open-field. Behav Brain Res 1998; 93: 25-32
47. Apelqvist G, Hindfelt B, Andersson G, Bengtsson F. Altered adaptive behaviour expressed in an open-field paradigm in experimental hepatic encephalopathy. Behav Brain Res 1999; 106: 165-173
48. Lozeva V, Valjakka A, Lecklin A, Olkkonen H, Hippelainen M, Itkonen M, Plumed C, Tuomisto L. Effects of the histamine H(1) receptor blocker, pyrilamine, on spontaneous locomotor activity of rats with long-term portacaval anastomosis. Hepatology 2000; 31: 336-344
49. Martin JR, Oettinger R, Battig K. Behavioral effects of experimental portacaval anastomosis measured in Dashiell and radial tunnel maze configurations. Physiol Behav 1986; 38: 21-24
50. Burkhard PR, Delavelle J, Du Pasquier R, Spahr L. Chronic parkinsonism associated with cirrhosis: a distinct subset of acquired hepatocerebral degeneration. Arch Neurol 2003; 60: 521-528
51. Kulisevsky J, Pujol J, Balanzo J, Junque C, Deus J, Capdevilla A, Villanueva C. Pallidal hyperintensity on magnetic resonance imaging in cirrhotic patients: clinical correlations. Hepatology 1992; 16: 1382-1388
52. Spahr L, Butterworth RF, Fontaine S, Bui L, Therrien G, Milette PC, Lebrun LH, Zayed J, Leblanc A, Pomier-Layrargues G. Increased blood manganese in cirrhotic patients: relationship to pallidal magnetic resonance signal hyperintensity and neurological symptoms. Hepatology 1996; 24: 1116-1120
53. Lockwood AH, Yap EW, Rhoades HM, Wong WH. Altered cerebral blood flow and glucose metabolism in patients with liver disease and minimal encephalopathy. J Cereb Blood Flow Metab 1991; 11: 331-336
54. Weissenborn K, Kolbe H. The basal ganglia and portal-systemic encephalopathy. Metab Brain Dis 1998; 13: 261-272
55. Amodio P, Montagnese S, Gatta A, Morgan MY. Characteristics of minimal hepatic encephalopathy. Metab Brain Dis 2004; 19: 253-267
56. Turski L, Klockgether T, Turski W, Schwarz M, Sontag KH. Substantia nigra and motor control in the rat: effect of intranigral alpha-kainate and gamma-D-glutamylaminomethylsulphonate on motility. Brain Res 1987; 424: 37-48
57. Millan MH, Wardley-Smith B, Halsey MJ, Meldrum BS. Studies on the role of the NMDA receptor in the substantia nigra pars reticulata and entopeduncular nucleus in the development of the high pressure neurological syndrome in rats. Exp Brain Res 1989; 78: 174-178
58. Trevitt T, Carlson B, Correa M, Keene A, Morales M, Salamone JD. Interactions between dopamine D1 receptors and gamma-aminobutyric acid mechanisms in substantia nigra pars reticulata of the rat: neurochemical and behavioral studies. Psychopharmacology (Berl) 2002; 159: 229-237
59. Kaur S, Starr MS. Differential effects of intrastriatal and intranigral injections of glutamate antagonists on motor behaviour in the reserpine-treated rat. Neuroscience 1997; 76: 345-354